Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

Alberto Guillén

◀ ▶ joint publications with Daniel Castillo-Secilla

> Home > Persons > Alberto Guillén

Publications

2022
[c58]
- view
  authority control:
- export record
  dblp key:
  - conf/iwbbio/Castillo-Secilla22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/iwbbio/Castillo-Secilla22
Daniel Castillo-Secilla, Daniel Redondo-Sánchez, Luis Javier Herrera, Ignacio Rojas, Alberto Guillén:
Gene Expression Tools from a Technical Perspective: Current Approaches and Alternative Solutions for the KnowSeq Suite. IWBBIO (1) 2022: 404-414
2021
[j31]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/Carrillo-PerezM21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/Carrillo-PerezM21
Francisco Carrillo-Perez, Juan Carlos Morales, Daniel Castillo-Secilla, Yésica Molina-Castro, Alberto Guillén, Ignacio Rojas, Luis Javier Herrera:
Non-small-cell lung cancer classification via RNA-Seq and histology imaging probability fusion. BMC Bioinform. 22(1): 454 (2021)
[c57]
- view
  authority control:
- export record
  dblp key:
  - conf/biomesip/Carrillo-PerezM21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/biomesip/Carrillo-PerezM21
Francisco Carrillo-Perez, Juan Carlos Morales, Daniel Castillo-Secilla, Alberto Guillén, Ignacio Rojas, Luis Javier Herrera:
Comparison of Fusion Methodologies Using CNV and RNA-Seq for Cancer Classification: A Case Study on Non-Small-Cell Lung Cancer. BIOMESIP 2021: 339-349

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.